ResearchMoz

Canada Diabetes Market Report & Forecast 2011-2016

Publisher Name » IMARC
Published Date » 2011-05-15
No. Of Pages » 38
IMARC’s new report “Canada Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into the Canadian diabetes market. The report provides both current and future trends in the prevalence and demographical breakup of diabetes in Canada. The report has segmented the Canada diabetes market into two segments - Insulin and the Oral Antidiabetics market. For each of the aforementioned categories, the report provides historical and future market sales of key classes, key companies, key drugs and key molecules.

The research study serves as an exceptional tool to understand the market trends, therapeutic structure, competitive structure and the outlook of the Canadian diabetes market till 2016. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Canadian diabetes market in some form or the other.

Key Questions Answered in this Report:
  • What is the size and demographical breakup of the diabetes population in Canada?
  • How has the diabetes market behaved since 2005 and what are the expected trends till 2016?
  • What has been the historical performance of the Canadian Insulin market during 2005-2010 and its outlook till 2016?
  • What has been the performance of top classes, top players, top molecules and top drugs in the Insulin market during 2005-2010?
  • What has been the historical performance of the Oral Antidiabetics market during 2005-2010 and its outlook till 2016?
  • What has been the performance of top classes, top players, top molecules and top drugs in the Oral Antidiabetics market during 2005-2010?
Why should you buy this report?
  • Gain a deeper understanding about the prevalence of diabetes in Canada and identify your potential patient pool.
  • Analyze the historical, current and future trends in the Insulin and Oral Antidiabetic markets and identify potential classes, drugs, partners and competitors for market entry and expansion plans.
  • Develop Investment strategies by identifying companies that have been the biggest winners and losers in the Canadian Insulin and Oral Antidiabetic markets.
  • Gain an insight into future market events such as biosimilars and new product launches.
Classes Covered: Fast acting Insulin, Long acting Insulin, Intermediate and Fast acting Insulin, Intermediate acting Insulin, Biguanides, Glitazone and Biguanide Combinations, Biguanide and Sulphonylurea Combinations, Glinides, Sulphonylureas, Glitazones, DPP-IV Inhibitors, Glp-1 Agonists, Alpha-Glucosidase Inhibitors, DPP-IV Inhibitor and Biguanide Combinations, DPP-IV Inhibitor and Glitazone Combinations, Glitazone and Sulphonylurea Combinations, SGLT Inhibitors, SGLT Inhibitor and Biguanide Combinations, PTP1B Inhibitors and all other Oral Antidiabetic classes.

Information Sources: Information has been sourced from both primary and secondary sources:
  • Primary sources include industry surveys and face to face/telephone interviews with physicians and industry experts.
  • Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, Industry Portals, government sources and access to more than 4000 paid databases.
Forecasting Methodology: IMARC generates its product and market forecasts utilizing its extensive database of macroeconomic and sector specific data. The initial baseline forecast is generated with the most recent market data. After an initial baseline forecast, all future macroeconomic and sector specific events and assumptions are taken into account to generate the final forecast.
1 Executive Summary
2 Epidemiology
2.1 Total Diabetes Patients
2.2 Patients by Gender
2.3 Patients by Age Group
3 Market Dynamics
3.1 Diabetes Market
3.1.1 Current Trends (2005-2010)
3.1.2 Market Forecast (2011-2016)
3.2 Insulin Market
3.2.1 Current Trends (2005-2010)
3.2.1.1 Market by Class
3.2.1.2 Market by Molecule
3.2.1.3 Top Players
3.2.1.4 Top Drugs
3.2.2 Market Forecast (2011-2016)
3.3 Oral Antidiabetics
3.3.1 Current Trends (2005-2010)
3.3.1.1 Market by Class
3.3.1.2 Top Players
3.3.1.3 Top Drugs
3.3.2 Market Forecast (2011-2016)
List of Figures
Figure 2 1: Canada - Number of Diabetes Patients* (in 000’s), 2010, 2015, 2020, 2025 & 2030
Figure 2 2: Canada - Breakup of Diabetes Patients by Gender* (in 000’s), 2010, 2015, 2020, 2025 & 2030
Figure 2 3: Canada - Breakup of Diabetes Patients by Gender* (in %) 2010, 2015, 2020, 2025 & 2030
Figure 2 4: Canada - Breakup of Diabetes Patients* by Age Group (in 000’s), 2010, 2015, 2020, 2025 & 2030
Figure 2 5: Canada - Breakup of Diabetes Patients* by Age Group (in %) 2010, 2015, 2020, 2025 & 2030
Figure 3 1: Canada - Diabetes Market (in Million US$), 2005-2010
Figure 3 2: Canada - Diabetes Market - Breakup of Insulin and Oral Antidiabetics (in %), 2005-2010
Figure 3 3: Canada - Diabetes Market Forecast (in Million US$), 2011-2016
Figure 3 4: Canada - Diabetes Market - Breakup of Insulin and Oral Antidiabetics (in %), 2011-2016
Figure 3 5: Canada - Insulin Market (in Million US$), 2005-2010
Figure 3 6: Canada - Insulin Market - Share by Class (in %), 2005-2010
Figure 3 7: Canada - Insulin Market - Share by Molecules (in %), 2005-2010
Figure 3 8: Canada - Insulin Market - Share of Key Players (in %), 2005-2010
Figure 3 9: Canada - Insulin Market - Share of Key Drugs (in %), 2005-2010
Figure 3 10: Canada - Insulin Market Forecast (in Million US$), 2011-2016
Figure 3 11: Canada - Oral Antidiabetics Market, (in Million US$), 2005-2010
Figure 3 12: Canada - Oral Antidiabetics Market - Share by Class (in %), 2005-2010
Figure 3 13: Canada - Oral Antidiabetics Market - Share of Key Players (in %), 2005-2010
Figure 3 14: Canada - Oral Antidiabetics Market - Share of Key Drugs (in %), 2005-2010
Figure 3 15: Canada - Oral Antidiabetics Market Forecast (in Million US$), 2011-2016
Figure 3 16: Canada - Oral Antidiabetics Market - Share Forecast by Class (%), 2010-2016
List of Tables
Table 1 1: Canada - Oral Antidiabetics & Insulin Market Definitions
Table 3 1: Canada - Insulin Market - Sales by Class (in Million US$), 2005-2010
Table 3 2: Canada - Insulin Market - Sales by Molecule (in Million US$), 2005-2010
Table 3 3: Canada - Insulin Market - Share of Key Players (in Million US$), 2005-2010
Table 3 4: Canada - Insulin Market - Sales of Key Drugs (in Million US$), 2005-2010
Table 3 5: Canada - Oral Antidiabetics Market - Sales by Class (in Million US$), 2005-2010
Table 3 6: Canada - Oral Antidiabetics Market - Sales of Key Players (in Million US$), 2005-2010
Table 3 7: Canada - Oral Antidiabetics Market - Sales of Key Drugs (in Million US$), 2005-2010
Table 3 8: Canada - Oral Antidiabetics - Sales Forecast by Class, (in Million US$), 2010, 2013 & 2016
Table 3 9: Canada - Oral Antidiabetics Market - New Drug Launches (2011-2016)

List of Tables


List of Figures

Upcoming Reports:

Power Lawn And Garden Equipment Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Demand for power lawn and garden equipment is rising considerably mainly because of improvements in housing activities like new construction and single family home sales. Currently, the residential market dominates the power lawn and garden equipment market owing to increasing concerns of people towards gardens. Also, this market is gaining momentum in the commercial sector, particularly golf courses. Government funding and positive response from private firms for development of landscapes is expected to double the growth rate of this market.  Market...
HPV Testing Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
The cancer diagnostics market is on the verge of sudden increase due to the technological breakthroughs in tumor diagnosis and unlocking of mysteries of genetics. The HPV (Human Papilloma Virus) testing market is expected to witness a promising growth in the next few years due to rising incidences of cancerous tumors and the growing ageing population.  Predictable technological breakthroughs are creating a number of opportunities for genetic study, detecting specific tumors, and monitoring biological responses to cancer therapy. Rise in the elderly population will further...
Chiral Technology Market - Global Industry Forecast, Market Share, Size, Growth And Industry Analysis (2011-2017)
By - Transparency Market Research
Chiral technology is widely spread in human life for instance, drugs for treating diseases, hair sprays, clothes and other several materials are composed of chiral molecules. The global market of chiral technology was USD 4.75 billion by 2010 and expected to reach at USD 5.83 billion by 2017 at an estimated CAGR of 3.05% between 2010 and 2017. Chiral technology market can be segmented into three sub markets: Chiral synthesis market Chiral resolution market Chiral analysis market  Chiral synthesis market possesses maximum potential as it accounts more than...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...